ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
暂无分享,去创建一个
[1] S. Moncada,et al. The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.
[2] S. Moncada,et al. Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.
[3] M. Feelisch,et al. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. , 1987, European journal of pharmacology.
[4] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[5] H. Vanderstichele,et al. Release of endothelium-derived relaxing factor from human umbilical vessels. , 1987, Circulation research.
[6] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[7] P. Sever,et al. Human vascular smooth muscle responses mediated by alpha 2 mechanisms in vivo and in vitro. , 1985, Clinical science.
[8] P. Angelberger,et al. Platelet labeling with in-111 oxine: benefit of prostacyclin (PgI2)--addition for preparation and injection. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] J. Vane,et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.
[10] F. Roughton,et al. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin , 1957, The Journal of physiology.